Exciting news from Dioseve as the company recently announced raising $7 million in funding. Dioseve is a groundbreaking biotech company specializing in developing technologies to create fertilizable eggs from iPS cells and ES cells. Their innovative approach aims to provide a solution for couples struggling with infertility by offering oocytes for assisted reproduction. The funding will be used to further advance their research and development efforts in the field of reproductive technology, with the ultimate goal of establishing a new and effective treatment for infertility. This substantial investment will propel Dioseve towards realizing their mission of revolutionizing infertility treatment and offering hope to those in need of alternative reproductive options.








